In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Member Benefit

This content is only available year-round to ESC Professional Members, Fellows of the ESC, and Young Combined Members

The flu vaccine and mortality in hypertension. A Danish nationwide cohort study.

Session Young Investigator Award Session Population sciences

Speaker Daniel Modin

Event : ESC Congress 2019

  • Topic : hypertension
  • Sub-topic : Epidemiology, Prognosis, Outcome
  • Session type : Young Investigator Award Abstracts

Authors : D Modin (Copenhagen,DK), B Claggett (Boston,US), ME Joergensen (Copenhagen,DK), L Koeber (Copenhagen,DK), T Benfield (Copenhagen,DK), M Schou (Copenhagen,DK), JU Jensen (Copenhagen,DK), S Solomon (Boston,US), R Trebbien (Copenhagen,DK), M Fralick (Toronto,CA), O Vardeny (Minneapolis,US), MA Pfeffer (Boston,US), C Torp-Pedersen (Aalborg,DK), G Gislason (Copenhagen,DK), T Biering-Soerensen (Copenhagen,DK)

D. Modin1 , B. Claggett2 , M.E. Joergensen1 , L. Koeber3 , T. Benfield4 , M. Schou1 , J.U. Jensen5 , S. Solomon2 , R. Trebbien6 , M. Fralick7 , O. Vardeny8 , M.A. Pfeffer2 , C. Torp-Pedersen9 , G. Gislason1 , T. Biering-Soerensen1 , 1Herlev & Gentofte Hospital, University of Copenhagen, Department of Cardiology - Copenhagen - Denmark , 2Brigham and Womens Hospital, Cardiovascular Medicine Division - Boston - United States of America , 3Rigshospitalet, University of Copenhagen, Department of Cardiology - Copenhagen - Denmark , 4Hvidovre Hospital, University of Copenhagen, Department of Infectious Diseases - Copenhagen - Denmark , 5Herlev & Gentofte Hospital, University of Copenhagen, Respiratory Medicine Section - Copenhagen - Denmark , 6Statens Serum Institut, Department of Virus and Microbiological Special Diagnostics - Copenhagen - Denmark , 7University of Toronto, Department of Medicine - Toronto - Canada , 8University of Minnesota, Center for Chronic Disease Outcomes Research - Minneapolis - United States of America , 9Aalborg University, Departments of Cardiology and Epidemiology/Biostatistics - Aalborg - Denmark ,

Hypertension – Epidemiology, Prognosis, Outcome

European Heart Journal ( 2019 ) 40 ( Supplement ), 725

Background: Influenza infection is associated with an increased risk of acute myocardial infarction (AMI) and stroke. It is currently unknown whether influenza vaccination may reduce mortality in patients with hypertension.

Purpose: To determine whether influenza vaccination is associated with lower risks of death in hypertensive patients without significant cardiovascular or other chronic disease.

Methods: Using nationwide registers, we identified all patients with hypertension in Denmark during 9 consecutive influenza seasons in the period 2007–2016 who were treated with at least 2 different classes of antihypertensive medication (beta-blockers, diuretics, calcium antagonists or renin-angiotensin system inhibitors). Patients who were not 18–100 years old or had ischemic heart disease, heart failure, chronic obstructive lung disease, cancer or cerebrovascular disease were excluded. Prior to each influenza season we assessed the exposure to influenza vaccination. End-points were death from all causes, from AMI or stroke, or cardiovascular death. For each season, patients were followed from December 1 until April 1 the next year, spanning the period of high influenza activity in Denmark.

Results: A total of 608,452 Patients were followed for a median of 5 seasons (interquartile-range: 2–8 seasons), with total follow-up time of 975,902 person-years. The vaccine coverage during study seasons ranged from 26% to 36%. During follow-up, 21,571 patients died of all-causes (3.5%), 12,270 patients died of cardiovascular causes (2.0%) and 3,846 patients died of AMI/stroke (0.6%). Vaccination was associated with older age, Diabetes Mellitus, atrial fibrillation, lower educational level, lower income and higher medication use. In unadjusted analysis considering all seasons, vaccination was significantly associated with increased risk of all-cause death, cardiovascular death and death from AMI/stroke. However, following adjustment for season, age, sex, comorbidities, medications, income, education, and more, vaccination was significantly associated with reduced risks of all-cause death, cardiovascular death and death from AMI/stroke (Figure).

Conclusion: In a nationwide study spanning 9 consecutive influenza seasons including more than 600,000 hypertensive patients without significant cardiovascular disease identified through medication use, influenza vaccination was significantly associated with a reduced risk of death from all-causes, cardiovascular causes and AMI/stroke. Influenza vaccination may improve patient outcome in hypertension.

PY, person-years.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are